# Lonza Biologics Tuas Pte Ltd, Singapore, Singapore – FDA Inspections

Source: https://www.keypedia.com/companies/lonza-biologics-tuas-pte-ltd/6b75fc9a-7ef0-4669-ae9a-1ac86fbff0f8

> Inspection records and compliance data for Lonza Biologics Tuas Pte Ltd in Singapore. 7 FDA inspections on record, 2 Form 483s, last inspected June 27, 2023.

---

## Details

- Name: Lonza Biologics Tuas Pte Ltd
- FEI Number: 3009725845
- Address Line 1: 35 Tuas South Avenue 6
- City: Singapore
- Country Name: Singapore
- Address: 35 Tuas South Avenue 6, Singapore, Singapore
- Country: Singapore

## Related Documents

- [FDA Inspection 1277712 - Lonza Biologics Tuas Pte Ltd - 2023-06-27](https://www.keypedia.com/records/fda_inspections/lonza-biologics-tuas-pte-ltd/b977ab1c-8f4f-45cb-bd21-c28e3cb62ac2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2023
- FDA Inspection 1255011 - Lonza Biologics Tuas Pte Ltd - 2023-05-19 — source: FDA, date: May 19, 2023
- [FDA Inspection 1107165 - Lonza Biologics Tuas Pte Ltd - 2019-09-20](https://www.keypedia.com/records/fda_inspections/lonza-biologics-tuas-pte-ltd/7df57cf9-03c2-47be-9348-593423eacdaf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2019
- [FDA Inspection 1108095 - Lonza Biologics Tuas Pte Ltd - 2019-06-18](https://www.keypedia.com/records/fda_inspections/lonza-biologics-tuas-pte-ltd/87b471a1-aaea-40d7-a874-a1feaaba76f7) — source: FDA, date: June 18, 2019
- FDA Inspection 1016852 - Lonza Biologics Tuas Pte Ltd - 2017-02-24 — classification: No Action Indicated (NAI), source: FDA, date: February 24, 2017
- FDA Inspection 925069 - Lonza Biologics Tuas Pte Ltd - 2015-03-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 10, 2015
- [FDA Inspection 834646 - Lonza Biologics Tuas Pte Ltd - 2012-08-03](https://www.keypedia.com/records/fda_inspections/lonza-biologics-tuas-pte-ltd/a9aafcfc-bbd1-4e58-a6c7-3cbabfc7c3d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 3, 2012

## Related Companies

- [Ipsen BioPharm Ltd](https://www.keypedia.com/companies/ipsen-biopharm-ltd/282b5a9a-91d6-43f7-b345-aa6fede30025)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Sanofi-Aventis Deutschland GmbH](https://www.keypedia.com/companies/sanofi-aventis-deutschland-gmbh/07c96432-bb43-45e5-a80d-e4bca284dbab)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
